3-46373394-C-G
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001394783.1(CCR5):c.492C>G(p.Ile164Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,612,246 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars).
Frequency
Consequence
NM_001394783.1 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| CCR5 | NM_001394783.1 | c.492C>G | p.Ile164Met | missense_variant | Exon 2 of 2 | ENST00000292303.5 | NP_001381712.1 | 
Ensembl
Frequencies
GnomAD3 genomes  0.0000396  AC: 6AN: 151630Hom.:  0  Cov.: 32 show subpopulations 
GnomAD2 exomes  AF:  0.0000358  AC: 9AN: 251256 AF XY:  0.0000295   show subpopulations 
GnomAD4 exome  AF:  0.00000890  AC: 13AN: 1460616Hom.:  0  Cov.: 32 AF XY:  0.00000963  AC XY: 7AN XY: 726618 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000396  AC: 6AN: 151630Hom.:  0  Cov.: 32 AF XY:  0.0000540  AC XY: 4AN XY: 74042 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not provided    Uncertain:1 
The CCR5 p.Ile164Met variant was identified in the literature however the frequency of this variant in an affected population was not provided. The variant was also identified in dbSNP (ID: rs1800942) and LOVD 3.0 (Effect on protein unknown). The variant was not identified in ClinVar or Cosmic. The variant was identified in control databases in 9 of 251256 chromosomes at a frequency of 0.000036 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: European (non-Finnish) in 8 of 113576 chromosomes (freq: 0.00007) and Latino in 1 of 34586 chromosomes (freq: 0.000029); it was not observed in the African, Ashkenazi Jewish, East Asian, European (Finnish), Other, and South Asian populations. In an in vitro study, it was found that the variant may be capable of disrupting ribosomal frameshifting activity (Belew_2014_PMID: 25043019). The p.Ile164 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at